Cargando…
Integrative discovery of treatments for high-risk neuroblastoma
Despite advances in the molecular exploration of paediatric cancers, approximately 50% of children with high-risk neuroblastoma lack effective treatment. To identify therapeutic options for this group of high-risk patients, we combine predictive data mining with experimental evaluation in patient-de...
Autores principales: | Almstedt, Elin, Elgendy, Ramy, Hekmati, Neda, Rosén, Emil, Wärn, Caroline, Olsen, Thale Kristin, Dyberg, Cecilia, Doroszko, Milena, Larsson, Ida, Sundström, Anders, Arsenian Henriksson, Marie, Påhlman, Sven, Bexell, Daniel, Vanlandewijck, Michael, Kogner, Per, Jörnsten, Rebecka, Krona, Cecilia, Nelander, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941971/ https://www.ncbi.nlm.nih.gov/pubmed/31900415 http://dx.doi.org/10.1038/s41467-019-13817-8 |
Ejemplares similares
-
Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts
por: Almstedt, Elin, et al.
Publicado: (2021) -
Modeling glioblastoma heterogeneity as a dynamic network of cell states
por: Larsson, Ida, et al.
Publicado: (2021) -
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
por: Persson, Camilla U., et al.
Publicado: (2017) -
p53-Mediated Radiosensitization of (177)Lu-DOTATATE in Neuroblastoma Tumor Spheroids
por: Lundsten, Sara, et al.
Publicado: (2021) -
Inference of glioblastoma migration and proliferation rates using single time-point images
por: Rosén, Emil, et al.
Publicado: (2023)